285 related articles for article (PubMed ID: 25824316)
1. Comparison of transarterial chemoembolization and hepatic resection for large solitary hepatocellular carcinoma: a propensity score analysis.
Lee YB; Lee DH; Cho Y; Yu SJ; Lee JH; Yoon JH; Lee HS; Kim HC; Yi NJ; Lee KW; Suh KS; Chung JW; Kim YJ
J Vasc Interv Radiol; 2015 May; 26(5):651-9. PubMed ID: 25824316
[TBL] [Abstract][Full Text] [Related]
2. Hepatic resection vs. transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria with portal hypertension.
Yang J; Yang JY; Yan LN; Wen TF; Li B; Wang WT
Dig Liver Dis; 2018 Jul; 50(7):713-719. PubMed ID: 29622387
[TBL] [Abstract][Full Text] [Related]
3. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.
Zhang DZ; Wei XD; Wang XP
World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of hepatic resection vs transarterial chemoembolization for solitary huge hepatocellular carcinoma.
Zhu SL; Zhong JH; Ke Y; Ma L; You XM; Li LQ
World J Gastroenterol; 2015 Aug; 21(32):9630-7. PubMed ID: 26327771
[TBL] [Abstract][Full Text] [Related]
5. Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis.
Zhu SL; Ke Y; Peng YC; Ma L; Li H; Li LQ; Zhong JH
PLoS One; 2014; 9(12):e115834. PubMed ID: 25541684
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: propensity score analysis.
Jiang JH; Guo Z; Lu HF; Wang XB; Yang HJ; Yang FQ; Bao SY; Zhong JH; Li LQ; Yang RR; Xiang BD
World J Gastroenterol; 2015 Apr; 21(15):4627-34. PubMed ID: 25914472
[TBL] [Abstract][Full Text] [Related]
7. Impact of the Interval between Transarterial Chemoembolization Sessions on Survival in Patients with Unresectable Hepatocellular Carcinoma.
Kim HD; An J; Kim JH; Gwon DI; Shin JH; Ko GY; Yoon HK; Sung KB; Kim KM; Lee HC
J Vasc Interv Radiol; 2016 Apr; 27(4):504-13. PubMed ID: 26896049
[TBL] [Abstract][Full Text] [Related]
8. Comparison of survival of patients with BCLC stage A hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: a propensity score-based analysis.
Guo Z; Zhong JH; Jiang JH; Zhang J; Xiang BD; Li LQ
Ann Surg Oncol; 2014 Sep; 21(9):3069-76. PubMed ID: 24728740
[TBL] [Abstract][Full Text] [Related]
9. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
[TBL] [Abstract][Full Text] [Related]
10. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival after surgical resection for huge hepatocellular carcinoma: comparison with transarterial chemoembolization after propensity score matching.
Min YW; Lee JH; Gwak GY; Paik YH; Lee JH; Rhee PL; Koh KC; Paik SW; Yoo BC; Choi MS
J Gastroenterol Hepatol; 2014 May; 29(5):1043-8. PubMed ID: 24863186
[TBL] [Abstract][Full Text] [Related]
12. Combined resection and radiofrequency ablation versus transarterial embolization for intermediate-stage hepatocellular carcinoma: A propensity score matching study.
Espinosa W; Liu YW; Wang CC; Lin CC; Wang JH; Lu SN; Hung CH
J Formos Med Assoc; 2018 Mar; 117(3):197-203. PubMed ID: 28411877
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of hepatic resection and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria].
Guo Z; Xiang B; Zhang J; Jiang J; Li L
Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1526-9. PubMed ID: 25146737
[TBL] [Abstract][Full Text] [Related]
14. Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis.
Hsu CY; Hsia CY; Huang YH; Su CW; Lin HC; Pai JT; Loong CC; Chiou YY; Lee RC; Lee FY; Huo TI; Lee SD
Ann Surg Oncol; 2012 Mar; 19(3):842-9. PubMed ID: 21913008
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Hepatocellular Carcinoma with Tumor Thrombus with the Use of Iodine-125 Seed Strand Implantation and Transarterial Chemoembolization: A Propensity-Score Analysis.
Zhang ZH; Zhang W; Gu JY; Liu QX; Ma JQ; Liu LX; Wang JH; Luo JJ; Yan ZP
J Vasc Interv Radiol; 2018 Aug; 29(8):1085-1093. PubMed ID: 29754851
[TBL] [Abstract][Full Text] [Related]
16. Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis.
Luo J; Peng ZW; Guo RP; Zhang YQ; Li JQ; Chen MS; Shi M
Radiology; 2011 Apr; 259(1):286-95. PubMed ID: 21330557
[TBL] [Abstract][Full Text] [Related]
17. Comparison of chemoembolization with and without radiation therapy and sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis.
Kim GA; Shim JH; Yoon SM; Jung J; Kim JH; Ryu MH; Ryoo BY; Kang YK; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
J Vasc Interv Radiol; 2015 Mar; 26(3):320-9.e6. PubMed ID: 25612807
[TBL] [Abstract][Full Text] [Related]
18. Role of hepatic resection in patients with intermediate-stage hepatocellular carcinoma: A multicenter study from Japan.
Tada T; Kumada T; Toyoda H; Tsuji K; Hiraoka A; Itobayashi E; Nouso K; Kariyama K; Ishikawa T; Hirooka M; Hiasa Y
Cancer Sci; 2017 Jul; 108(7):1414-1420. PubMed ID: 28406546
[TBL] [Abstract][Full Text] [Related]
19. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
[TBL] [Abstract][Full Text] [Related]
20. Survival Outcome Between Hepatic Resection and Transarterial Embolization for Hepatocellular Carcinoma More Than 10 cm: A Propensity Score Model.
Chan YC; Kabiling CS; Pillai VG; Aguilar G; Wang CC; Chen CL
World J Surg; 2015 Jun; 39(6):1510-8. PubMed ID: 25665673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
